EladSharonMD

PubMed

• Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.
  Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason J Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwa...> ;Journal of Clinical Oncology. 2024 Mar 20
• Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical Practice.
  Elad Sharon> ;JAMA Oncology. 2024 Mar 7
• Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
  Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong, Lucia Kwak, Marita Salame, Elias Bou Farhat, Dory Freeman, Edward El-Am, Arjun Ravishank...> ;Journal for Immunotherapy of Cancer. 2024 Mar 5
• Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
  Roisin M Connolly, Victoria Wang, David M Hyman, Petros Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert J Gray, Lisa M McShane, Larry V Rubinstein, David ...> ;Clinical Cancer Research. 2024 Apr 1
• SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
  Guadarrama, E., Ferri, W., Othus, M., Lopez, G., Patel, S., Chae, Y., Dennis, M., Powers, B., Liao, C., George, T., Sharon, E., Ryan, C., Blanke, C., Kurzrock, R.> ;Cancer. 2024 Feb 15
• SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational stu...
  Hill, J., Martens, M., Young, J., Bhavsar, K., Kou, J., Chen, M., Lee, L., Baluch, A., Dhodapkar, M., Nakamura, R., Peyton, K., Howard, D., Ibrahim, U., Shahid, Z., Ar...> ;Medrxiv. 2024 Jan 25
• Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.
  Baginska, J., Nau, A., Gomez Diaz, I., Giobbie-Hurder, A., Weirather, J., Vergara, J., Abrecht, C., Hallisey, M., Dennis, J., Severgnini, M., Huezo, J., Marciello, I.,...> ;Cancer Immunology, Immunotherapy. 2024 Jan 18
• Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial.
  Othus, M., Chae, Y., Dietrich, E., Streicher, H., Patel, S., Sharon, E., Kurzrock, R.> ;Journal of the National Cancer Institute. 2024 Jan 18
• A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or ...
  Jan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E Roe, Jonathan M Irish, Anne Caldwell, Wei Wei, Abdulraheem Yacoub, Yazan ...> ;Annals of Hematology. 2024 Jan 1
• A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
  Megan Othus, David Mutch, Wolfram Samlowski, Elad Sharon, Gabby Lopez, Melissa Plets, Patel, S., Chae, Y., Dennis, M., Gordon, S., Robinson, W., Ryan, C., Blanke, C., ...> ;Clinical Cancer Research. 2024 Jan 5
• 1 citations
  The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.
  Ananth Annapragada, Andrew G Sikora, Himangi Marathe, Song Liu, Michael Demetriou, Lawrence Fong, Jinming Gao, Donald Kufe, Zachary S Morris, Eduardo Vilar, Elad Sharo...> ;Journal of the National Cancer Institute. 2023 Nov 8
• 2 citations
  Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
  Paul G Rubinstein, Page C Moore, Milan Bimali, Jeanette Y Lee, Michelle A Rudek, Amy Chadburn, Lee Ratner, David H Henry, Ethel Cesarman, Camille E DeMarco, Dominique ...> ;The Lancet. Haematology. 2023 Aug 1
• 7 citations
  Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...
  Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
• Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having.
  Elad Sharon, Megan Othus, Zoe Eloise Quandt> ;Cancer. 2023 Sep 15
• 1 citations
  Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development.
  Harriet M Kluger, Hussein Tawbi, David Feltquate, Theresa LaVallee, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Ryan J Sullivan> ;Journal for Immunotherapy of Cancer. 2023 Jul 1
• 6 citations
  Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
  Laura E Hogan, Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J Borowitz, Elizabeth A Raetz, Andrew Carroll, Nyla A Heerema, Gerhard ...> ;Journal of Clinical Oncology. 2023 Sep 1
• Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs.
  Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc...> ;Journal for Immunotherapy of Cancer. 2023 May 1
• 10 citations
  SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.
  Hill, J., Martens, M., Young, J., Bhavsar, K., Kou, J., Chen, M., Lee, L., Baluch, A., Dhodapkar, M., Nakamura, R., Peyton, K., Shahid, Z., Armistead, P., Westervelt, ...> ;Eclinicalmedicine. 2023 May 1
• 1 citations
  The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018.
  Nadia Howlader, Elad Sharon, Manami Bhattacharya, Lori A Ehrlich, Nicholas C Richardson, Nicole J Gormley, R Angelo de Claro, Amy E Wood, Angela B Mariotto, Kathleen A...> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Jun 1
• 1 citations
  Design of phase II oncology trials evaluating combinations of experimental agents.
  Elad Sharon, Jared C Foster> ;Journal of the National Cancer Institute. 2023 Jun 8
• 113 citations
  Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
  Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost, John R Hyngstrom, Siwen Hu-Lieskovan, Christopher D Lao, Leslie A Fecher, Thach-Giao Truon...> ;The New England Journal of Medicine. 2023 Mar 2
• 4 citations
  Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.
  Shankar, L., Schöder, H., Sharon, E., Wolchok, J., Knopp, M., Wahl, R., Ellingson, B., Hall, N., Yaffe, M., Towbin, A., Farwell, M., Pryma, D., Poussaint, T., Wright, ...> ;The Lancet. Oncology. 2023 Mar 1
• 20 citations
  Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.
  Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Rieme...> ;Journal for Immunotherapy of Cancer. 2023 Mar 1
• 6 citations
  Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors.
  Harriet Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein Tawbi, Elad...> ;Journal for Immunotherapy of Cancer. 2023 Mar 1
• 2 citations
  The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibo...
  Qi Liu, Raina Mathur, Yuan Xu, Aracelis Z Torres, Rebecca A Miksad, Chao Liu, Haixia Smithson, Yaning Wang, Hao Zhu, Brian Booth, Shiew-Mei Huang, Jizu Zhi, Rajeshwari...> ;Clinical Pharmacology and Therapeutics. 2023 May 1
• Join now to see all

Journal Articles

• Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 Study  
  Michael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer
• Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful Activity  
  Elad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research
• From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely  
  Arta M Monjazeb, Elad Sharon, Clinical Cancer Research

Abstracts/Posters

• Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
  Elad Sharon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019